Vetmedin®-CA1 Pimobendan Chewable Tablets is indicated for the delay of
onset of congestive heart failure in dogs with Stage B2 preclinical
myxomatous mitral valve disease.

▪Conditionally approved for the treatment of dogs with myxomatous mitral
valve disease (MMVD) in the pre-clinical stage B2 (asymptomatic with a
murmur/abnormal heart sounds and evidence of increased heart size) to
delay onset of clinical signs of heart failure
▪Cardiac drug for oral use in dogs only
▪Has not been evaluated in dogs younger than 6 months of age, dogs with
congenital heart defects, dogs with diabetes mellitus or other serious
metabolic diseases, dogs used for breeding, or pregnant or lactating
bitches